Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2597 Views
-
Last post by NHE
-
- 0 Replies
- 557 Views
-
Last post by NHE
-
- 6 Replies
- 7882 Views
-
Last post by ElliotB
-
- 0 Replies
- 3822 Views
-
Last post by NHE
-
- 0 Replies
- 1426 Views
-
Last post by NHE
-
- 0 Replies
- 691 Views
-
Last post by NHE
-
- 0 Replies
- 3508 Views
-
Last post by NHE
-
- 11 Replies
- 3536 Views
-
Last post by NHE
-
- 1 Replies
- 1165 Views
-
Last post by NHE